Table 3. Monitoring of Liver functions and related observations.
| Parameter | No (%) |
|---|---|
| LFT monitoring before initiation of statin | |
| Yes | 789 (85) |
| No | 138 (15) |
| LFT monitoring after initiation of statin | |
| Not done | 170 (18) |
| 1-2 times | 454 (45) |
| 3-4 times | 247 (27) |
| 5-6 times | 55 (6) |
| > 6 times | 1 (0.1) |
| LFT monitoring before increase in dose | |
| Yes | 38 (68) |
| No | 18 (32) |
| Parameter | No (%) |
| LFT monitoring after increase in dose | |
| Yes | 14 (25) |
| No | 42 (75) |
| Development of hepatic effects | |
| Yes | 132 (14) |
| No | 795 (86) |
| Hepatic effects suspected to be statin related | |
| Yes | 40 (30) |
| No | 92 (70) |
|
If not statin related, change in statin regimen |
|
| Yes | 9 (10) |
| No | 83 (90) |